Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced ... on application of biology, hit discovery, target discovery,” he said.

In this article, we present a framework designed to evaluate the progress and impact of AI tools across various use cases in drug discovery ... 20 drugs with disease-target associations identified ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery called TxGemma. The AI models, which Google ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Among the investors is GlaxoSmithKline, which is teaming up with the biotech startup in a multi-target ... rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine ...

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...